N.Y. U.S. Attorney: Federal Court Enters Injunction Against Herbal Drug Manufacturer for Selling Misbranded, Unapproved Drugs
June 05, 2020
June 05, 2020
NEW YORK, June 5 -- The U.S. Attorney for the Southern District of New York, Geoffrey S. Berman, issued the following news release:
Geoffrey S. Berman, the United States Attorney for the Southern District of New York, and Stacy Amin, Chief Counsel for the U.S. Food and Drug Administration ("FDA"), announced that the United States District Court for the Southern District of New York has entered an injunction against defendants RAHSAN A. HAKIM ("Hakim") and ADONIIA . . .
Geoffrey S. Berman, the United States Attorney for the Southern District of New York, and Stacy Amin, Chief Counsel for the U.S. Food and Drug Administration ("FDA"), announced that the United States District Court for the Southern District of New York has entered an injunction against defendants RAHSAN A. HAKIM ("Hakim") and ADONIIA . . .